ATE412737T1 - Virusreinigung mit ultrafiltration - Google Patents

Virusreinigung mit ultrafiltration

Info

Publication number
ATE412737T1
ATE412737T1 AT06724513T AT06724513T ATE412737T1 AT E412737 T1 ATE412737 T1 AT E412737T1 AT 06724513 T AT06724513 T AT 06724513T AT 06724513 T AT06724513 T AT 06724513T AT E412737 T1 ATE412737 T1 AT E412737T1
Authority
AT
Austria
Prior art keywords
ultrafiltration
virus
virus cleaning
adenovirus
cleaning
Prior art date
Application number
AT06724513T
Other languages
English (en)
Inventor
Miranda Weggeman
Original Assignee
Crucell Holland Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36572264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE412737(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Crucell Holland Bv filed Critical Crucell Holland Bv
Application granted granted Critical
Publication of ATE412737T1 publication Critical patent/ATE412737T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10051—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06724513T 2005-04-11 2006-04-11 Virusreinigung mit ultrafiltration ATE412737T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67006405P 2005-04-11 2005-04-11
EP05102842 2005-04-11

Publications (1)

Publication Number Publication Date
ATE412737T1 true ATE412737T1 (de) 2008-11-15

Family

ID=36572264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06724513T ATE412737T1 (de) 2005-04-11 2006-04-11 Virusreinigung mit ultrafiltration

Country Status (10)

Country Link
US (1) US8574595B2 (de)
EP (1) EP1869171B2 (de)
CN (1) CN101155915B (de)
AT (1) ATE412737T1 (de)
AU (1) AU2006233800B2 (de)
CA (1) CA2602944C (de)
DE (1) DE602006003420D1 (de)
DK (1) DK1869171T4 (de)
ES (1) ES2317517T5 (de)
WO (1) WO2006108707A1 (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101080488A (zh) * 2004-11-03 2007-11-28 因特罗根治疗公司 生产和纯化腺病毒载体的新方法
WO2007110409A1 (en) * 2006-03-27 2007-10-04 Crucell Holland B.V. Compositions comprising a recombinant adenovirus and an adjuvant
FR2907453B1 (fr) 2006-10-24 2008-12-26 Sanofi Aventis Sa Nouveaux derives du fluorene,compositions les contenant et utilisation
US20080131955A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA
EP2195418B1 (de) * 2007-10-02 2012-12-12 PTC Phage Technology Center GmbH Verfahren und system zur grosstechnischen aufreinigung von für eine bakteriophagentherapie vorgesehenen bakteriophagen
ATE525062T1 (de) * 2007-12-28 2011-10-15 Baxter Int Gegendruckfiltration von proteinen
US10273502B2 (en) * 2008-06-18 2019-04-30 Oxford Biomedica (Uk) Limited Virus purification
EA019928B1 (ru) 2008-11-03 2014-07-30 Круселл Холланд Б.В. Способ получения аденовирусных векторов
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
WO2011045381A1 (en) 2009-10-15 2011-04-21 Crucell Holland B.V. Process for adenovirus purification from high cell density cultures
MX2012004222A (es) 2009-10-15 2012-06-08 Crucell Holland Bv Metodo para purificacion de particulas de adenovirus.
PL2536829T3 (pl) 2010-02-15 2016-09-30 Sposób wytwarzania wektorów adenowirusowych Ad26
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
PL2575872T3 (pl) * 2010-06-01 2021-02-22 Seqirus UK Limited Zatężanie antygenów szczepionkowych grypy bez liofilizacji
EP2603234B1 (de) * 2010-08-12 2017-06-28 Yisheng Biopharma Holdings Ltd. Verfahren zur reduktion von dna-unreinheiten bei viralen zusammensetzungen
CA2808556A1 (en) 2010-09-20 2012-03-29 Crucell Holland B.V. Therapeutic vaccination against active tuberculosis
BR112013004582A2 (pt) 2010-09-27 2016-09-06 Crucell Holland Bv método para induzir uma resposta imune em um sujeito contra um antígeno de um parasita que causa a malária
PL2697369T3 (pl) 2011-03-25 2018-12-31 F.Hoffmann-La Roche Ag Nowe sposoby oczyszczania białek
KR102022952B1 (ko) * 2011-08-05 2019-09-20 신라젠(주) 백시니아 바이러스의 생산을 위한 방법 및 조성물
CN102688485A (zh) * 2011-09-16 2012-09-26 扬州优邦生物制药有限公司 一种猪细小病毒灭活疫苗的制备方法
WO2013074501A1 (en) 2011-11-14 2013-05-23 Crucell Holland B.V. Heterologous prime-boost immunization using measles virus-based vaccines
SG10201510800PA (en) * 2012-01-09 2016-01-28 Sanofi Pasteur Biologics Llc Purification of flaviviruses
US8932607B2 (en) 2012-03-12 2015-01-13 Crucell Holland B.V. Batches of recombinant adenovirus with altered terminal ends
KR102044051B1 (ko) 2012-03-12 2019-11-12 얀센 백신스 앤드 프리벤션 비.브이. 터미널 말단이 변경된 재조합 아데노바이러스의 배치
JP5845376B2 (ja) 2012-03-22 2016-01-20 クルセル ホランド ベー ヴェー Ｒｓｖに対するワクチン
US9125870B2 (en) 2012-03-22 2015-09-08 Crucell Holland B.V. Vaccine against RSV
CN103923883A (zh) * 2013-01-16 2014-07-16 辽宁成大生物股份有限公司 一种流感病毒的浓缩、纯化方法
PT2988780T (pt) 2013-04-25 2019-03-25 Janssen Vaccines & Prevention Bv Polipeptídeos f de pré-fusão do rsv solúveis estabilizados
CN105408348B (zh) 2013-06-17 2021-07-06 扬森疫苗与预防公司 稳定化的可溶性融合前rsv f多肽
CA2920191C (en) * 2013-07-18 2022-03-01 Children's Hospital Medical Center Methods of improving titer in transfection-based production systems using eukaryotic cells
CN103601793A (zh) * 2013-10-23 2014-02-26 乾元浩生物股份有限公司 一种禽用疫苗抗原纯化的方法
KR102707370B1 (ko) * 2014-05-13 2024-09-13 암겐 인코포레이티드 필터 및 여과 공정과 함께 사용하기 위한 공정 제어 시스템 및 방법
AU2015264168B2 (en) * 2014-05-21 2020-03-12 Unchained Labs Systems and methods for exchange of buffer solutions
DK3172317T3 (da) * 2014-07-24 2019-07-22 Janssen Vaccines & Prevention Bv Fremgangsmåde til oprensning af poliovirus fra cellekulturer
AU2016249798B2 (en) 2015-04-14 2022-05-26 Janssen Vaccines And Prevention B.V. Recombinant adenovirus expressing two transgenes with a bidirectional promoter
CN107847580B (zh) 2015-07-07 2022-08-12 扬森疫苗与预防公司 针对rsv的疫苗
AU2016289496B2 (en) 2015-07-07 2021-02-04 Janssen Vaccines & Prevention B.V. Stabilized soluble pre-fusion RSV F polypeptides
MX2018012094A (es) 2016-04-05 2019-01-10 Janssen Vaccines & Prevention Bv Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas.
AU2017248018A1 (en) 2016-04-05 2018-09-27 Janssen Vaccines & Prevention B.V. Vaccine against RSV
BR112018072865A2 (pt) 2016-05-12 2019-04-30 Janssen Vaccines & Prevention B.V. promotor bidirecional potente e equilibrado
SG11201810078PA (en) 2016-05-30 2018-12-28 Janssen Vaccines & Prevention Bv Stabilized pre-fusion rsv f proteins
US11001858B2 (en) 2016-06-20 2021-05-11 Janssen Vaccines & Prevention B.V. Potent and balanced bidirectional promoter
US10744196B2 (en) 2016-07-14 2020-08-18 Janssen Vaccines & Prevention B.V. HPV vaccines
EP3559216A1 (de) * 2016-12-22 2019-10-30 Blue Sky Vaccines GmbH Verfahren zur reinigung eines virus
JP6721797B2 (ja) 2017-02-09 2020-07-15 ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． 異種遺伝子発現のための強力で短いプロモーター
JP7262449B2 (ja) * 2017-05-15 2023-04-21 シー‐レクタ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 酵素産物
CA3061278A1 (en) 2017-05-17 2018-11-22 Janssen Vaccines & Prevention B.V. Methods and compositions for inducing protective immunity against rsv infection
CN107603959A (zh) * 2017-08-30 2018-01-19 四川大学 提高缓冲液盐离子浓度纯化病毒的方法
AU2018333566A1 (en) 2017-09-15 2020-02-27 Janssen Vaccines & Prevention B.V. Method for the safe induction of immunity against RSV
GB201806736D0 (en) * 2018-04-25 2018-06-06 Ge Healthcare Bioprocess R&D Ab Method for virus purification
PE20211469A1 (es) 2018-11-13 2021-08-05 Janssen Vaccines And Prevention B V Proteinas f de prefusion del vrs estabilizadas
CN111454914A (zh) * 2019-01-18 2020-07-28 嘉兴安宇生物科技有限公司 一种腺病毒快速纯化方法
WO2020229906A1 (en) * 2019-05-14 2020-11-19 Janssen Biotech, Inc. Efficient impurity removal using a diafiltration process
CN110129287B (zh) * 2019-05-15 2023-07-14 青岛蔚蓝生物制品有限公司 一种猪伪狂犬病毒双重超滤系统及纯化方法
CN111394390A (zh) * 2020-03-26 2020-07-10 赛诺（深圳）生物医药研究有限公司 用于新型冠状病毒基因疫苗的批量生产重组腺病毒的方法
CN111575244B (zh) * 2020-05-06 2021-07-23 江苏金迪克生物技术股份有限公司 一种低Vero细胞残留DNA狂犬病疫苗原液的制备方法
EP3919613B1 (de) * 2020-06-05 2024-08-07 Sartorius BIA Separations d.o.o. Verbesserte reinigung von adeno-assoziiertem virus um kontaminierende dna effektiver zu entfernen
CN112226418B (zh) * 2020-09-25 2022-07-08 阜外华中心血管病医院 重组腺相关病毒纯化方法
CA3203570A1 (en) * 2020-12-10 2022-06-16 Astrazeneca Uk Limited Methods of purifying adenovirus
CN112899242A (zh) * 2021-02-03 2021-06-04 苏州博腾生物制药有限公司 慢病毒纯化工艺
CN113373120B (zh) * 2021-06-18 2022-04-26 浙江康佰裕生物科技有限公司 Gmp级逆转录病毒载体的纯化方法与应用
CN113817689B (zh) * 2021-11-22 2023-10-03 北京艺妙神州医药科技有限公司 慢病毒纯化工艺
CN115747017B (zh) * 2022-10-25 2023-06-09 上海华新生物高技术有限公司 一种腺病毒纯化装置
CN116855461A (zh) * 2023-04-25 2023-10-10 浙江恒驭生物科技有限公司 一种呼肠孤病毒3型的纯化方法及应用

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE434914B (sv) * 1975-07-07 1984-08-27 Jonsson U R S Forfarande for att ur en suspension av bakterier och ett vetskeformigt medium genom filtrering avskilja mediet under samtidig anrikning av bakterierna
US4435289A (en) * 1981-12-23 1984-03-06 Romicon, Inc. Series ultrafiltration with pressurized permeate
US5173418A (en) * 1985-05-10 1992-12-22 Benzon Pharma, A/S Production in Escherichia coli of extracellular Serratia spp. hydrolases
US4808315A (en) * 1986-04-28 1989-02-28 Asahi Kasei Kogyo Kabushiki Kaisha Porous hollow fiber membrane and a method for the removal of a virus by using the same
FR2705686B1 (fr) * 1993-05-28 1995-08-18 Transgene Sa Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
FR2716682B1 (fr) * 1994-01-28 1996-04-26 Centre Nat Rech Scient Procédé de préparation de virus adéno-associés (AAV) recombinants et utilisations.
US5851806A (en) * 1994-06-10 1998-12-22 Genvec, Inc. Complementary adenoviral systems and cell lines
EP0784690B1 (de) * 1994-06-10 2006-08-16 Genvec, Inc. Adenoviren-vektor systeme und zelllinien
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US5965541A (en) * 1995-11-28 1999-10-12 Genvec, Inc. Vectors and methods for gene transfer to cells
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5770442A (en) 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
DE69633565T3 (de) * 1995-06-15 2013-01-17 Crucell Holland B.V. Verpackungssysteme für humane, menschliche adenoviren, zur verwendung in die gentherapie
FR2737730B1 (fr) * 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
JPH11511326A (ja) * 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびａａｖの精製
US5837511A (en) * 1995-10-02 1998-11-17 Cornell Research Foundation, Inc. Non-group C adenoviral vectors
US5891690A (en) * 1996-04-26 1999-04-06 Massie; Bernard Adenovirus E1-complementing cell lines
JP2000514290A (ja) * 1996-07-01 2000-10-31 ローヌ―プーラン・ロレ・エス・アー 組換えアデノウイルスの製造方法
FR2751343B1 (fr) * 1996-07-16 1998-12-18 Transgene Sa Procede de conservation de virus recombinants infectieux, suspension aqueuse virale et utilisation comme medicament
EP0968284B1 (de) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US7732129B1 (en) * 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
US6261823B1 (en) * 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6168944B1 (en) * 1997-01-31 2001-01-02 Schering Corporation Methods for cultivating cells and propagating viruses
IL131014A0 (en) 1997-01-31 2001-01-28 Schering Plough Corp Methods for cultivating cells and propagating viruses
CA2283253A1 (en) 1997-03-04 1998-09-11 Baxter International Inc. Adenovirus e1-complementing cell lines
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
US6020191A (en) * 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US5947689A (en) * 1997-05-07 1999-09-07 Scilog, Inc. Automated, quantitative, system for filtration of liquids having a pump controller
DE122009000037I2 (de) * 1997-08-28 2011-06-16 Cheil Jedang Corp Ein an vero-zellen angepasstes abgeschwächtes japanisches enzephalitis virus und ein impfstoff gegen japanische enzephalitis
US6210683B1 (en) 1997-09-05 2001-04-03 Merck & Co., Inc. Stabilizers containing recombinant human serum albumin for live virus vaccines
KR100918187B1 (ko) 1998-02-17 2009-09-22 쉐링 코포레이션 바이러스를 포함하는 조성물 및 바이러스 제제의 농축방법
US5981225A (en) * 1998-04-16 1999-11-09 Baylor College Of Medicine Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same
DE69927013T2 (de) * 1998-04-22 2006-06-29 Genvec, Inc. Effiziente reinigung von adenovirus
US5994134A (en) * 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6113913A (en) * 1998-06-26 2000-09-05 Genvec, Inc. Recombinant adenovirus
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
EP1133316B1 (de) 1998-11-16 2009-01-21 Introgen Therapeutics, Inc. Adenovirus-formulierungen zur gentherapie
AU779267B2 (en) * 1998-12-31 2005-01-13 Centelion S.A.S. Method for separating viral particles
CA2364934C (fr) 1999-02-22 2011-10-18 Transgene S.A. Procede d'obtention d'une preparation virale purifiee
US6120820A (en) * 1999-02-22 2000-09-19 Land O'lakes, Inc. Method of modifying the color of a dairy material
ATE519854T1 (de) 1999-05-17 2011-08-15 Crucell Holland Bv Rekombinantes adenovirus auf basis von serotyp 48 (ad48).
WO2003104467A1 (en) 2002-04-25 2003-12-18 Crucell Holland B.V. Means and methods for the production of adenovirus vectors
US6492169B1 (en) * 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
DE19955558C2 (de) 1999-11-18 2003-03-20 Stefan Kochanek Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren
EP1103610A1 (de) 1999-11-26 2001-05-30 Introgene B.V. Impfstoffherstellung von immortalisierten Säugetierzellinien
EP2420247A1 (de) 2000-03-07 2012-02-22 Merck Sharp & Dohme Corp. Adenovirus-Formulierungen
US6168941B1 (en) 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
DE10022258A1 (de) * 2000-05-08 2001-11-15 Bayer Ag Reinigung von Proteineinschlusskörpern durch Querstrom-Mikrofiltration
JP2004508064A (ja) 2000-09-15 2004-03-18 メルク　エンド　カムパニー　インコーポレーテッド コドン最適化ｈｉｖ１−ｇａｇ、ｐｏｌ、ｎｅｆおよび修飾体を発現する増強された第１世代アデノウイルスワクチン
US6365395B1 (en) * 2000-11-03 2002-04-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
IL152420A0 (en) 2001-02-23 2003-05-29 Novartis Ag Novel oncolytic adenoviral vectors
DE60238970D1 (de) 2001-03-01 2011-03-03 Bayer Schering Pharma Ag Zellen in derselben prozesseinheit
CA2462455C (en) 2001-10-01 2012-07-17 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Development of a preventive vaccine for filovirus infection in primates
CA2469491A1 (en) 2001-12-12 2003-06-19 Kerrie Setiawan Composition for viral preservation
US20030180936A1 (en) 2002-03-15 2003-09-25 Memarzadeh Bahram Eric Method for the purification, production and formulation of oncolytic adenoviruses
JP2005521417A (ja) 2002-03-29 2005-07-21 メルク　エンド　カムパニー　インコーポレーテッド アデノウイルスの大規模産生方法及びアデノウイルス種子ストック
CA2478508C (en) 2002-04-25 2013-07-02 Crucell Holland B.V. Stable adenoviral vectors and methods for propagation thereof
EP1506287B1 (de) * 2002-05-14 2007-04-25 Merck & Co., Inc. Verfahren zur reinigung von adenovirus
US20050095705A1 (en) 2003-04-15 2005-05-05 Michael Kadan Method for production of oncolytic adenoviruses
CA2529053A1 (en) * 2003-06-18 2004-12-29 Onyx Pharmaceuticals, Inc. Method for purifying virus
CN1922308A (zh) * 2004-02-23 2007-02-28 克鲁塞尔荷兰公司 病毒纯化方法

Also Published As

Publication number Publication date
DK1869171T3 (da) 2009-02-16
CN101155915B (zh) 2013-12-04
AU2006233800A1 (en) 2006-10-19
DE602006003420D1 (de) 2008-12-11
ES2317517T5 (es) 2016-01-21
CA2602944A1 (en) 2006-10-19
DK1869171T4 (en) 2016-01-18
US8574595B2 (en) 2013-11-05
CA2602944C (en) 2015-08-11
CN101155915A (zh) 2008-04-02
EP1869171B2 (de) 2015-10-14
EP1869171B1 (de) 2008-10-29
AU2006233800B2 (en) 2011-07-07
US20090123989A1 (en) 2009-05-14
ES2317517T3 (es) 2009-04-16
WO2006108707A1 (en) 2006-10-19
EP1869171A1 (de) 2007-12-26

Similar Documents

Publication Publication Date Title
DK1869171T3 (da) Virusrensning under anvendelse af ultrafiltrering
NL1026467A1 (nl) Composiet semipermeabel membraan, alsmede productiewerkwijze daarvoor.
EP2808393A3 (de) Fucosylierungsunfähige Zellen
NO20071158L (no) Membraner for separasjoner som krever hoy selektivitet
EA200702210A1 (ru) Способ очистки белков
WO2004094466A3 (en) Recombinant influenza viruses holding a mutation in a transmembrane protein gene
DK1940918T3 (da) Dimercaptanterminerede polythioetherpolymerer og fremgangsmåder til at fremstille og anvende samme
DK3081649T3 (da) Mikroorganisme, der producerer l-methionin-prækursor, og fremgangsmåden til produktion af l-methionin-prækursor ved anvendelse af mikroorganismen
BRPI0919083A2 (pt) processo para preparação de uma membrana, e, membrana assimétrica.
EP2365869A4 (de) Mikroporöse membran und herstellungsverfahren
BRPI0923267A2 (pt) sistema de recorte de painel de vidro para uso com um fio de corte no procedimento de recorte de uma painel de vidro de veiculo, metodo de cortar um painel de vidro de veiculo colado em uma moldura por meio de material de colagem interposto.
DK1780269T3 (da) Virusrensningsmetoder
UA97966C2 (ru) Механическое сцепление панелей пола с вертикальным складыванием
MY197183A (en) High flux, cross-linked, fumed silica reinforced polyorganosiloxane membranes for separations
DK1764025T3 (da) Sammenklappelig aftörringsplade
NZ596671A (en) Assays for influenza virus hemagglutinins
EA200802064A1 (ru) Обойма с выемками в основаниях кронштейнов
BRPI0813823B8 (pt) métodos para concentração de uma solução de imunoglobulina por filtração de fluxo tangencial, e para produção de uma imunoglobulina
FI20050452A0 (fi) Virtauskone, sen liukurengastiiviste, liukurengastiivisteen runkokappale ja menetelmä liukurengastiivisteen kiinnittämiseksi virtauskoneeseen
WO2008005470A3 (en) Polypeptides that bind membrane proteins
EP4074411A4 (de) Semipermeable verbundmembran
MY157998A (en) Suction tube device provided with drive systems and method of repairing same
EP3993112A4 (de) Gasdiffusionselektrode, verfahren zu ihrer herstellung und membranelektrodenanordnung
EA200702543A1 (ru) Циклопентадиенильно-флуоренильные лиганды с углеродными мостиками
WO2013190453A3 (en) Compositions for separation methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1869171

Country of ref document: EP